Safety and Immunogenicity of a Modified Self-Amplifying Ribonucleic Acid (saRNA) Vaccine Encoding SARS-CoV-2 Spike Glycoprotein in SARS-CoV-2 Seronegative and Seropositive Ugandan Individuals.
SARS-CoV-2 刺突糖蛋白编码的改良型自扩增核糖核酸 (saRNA) 疫苗在 SARS-CoV-2 血清阴性和血清阳性乌干达个体中的安全性和免疫原性
期刊:Vaccines
影响因子:3.4
doi:10.3390/vaccines13060553
Kitonsa Jonathan, Serwanga Jennifer, Cheeseman Hannah M, Abaasa Andrew, Lunkuse Jane Frances, Ruzagira Eugene, Kato Laban, Nambaziira Florence, Oluka Gerald Kevin, Gombe Ben, Jackson Sembera, Ssebwana Joseph Katende, McFarlane Leon R, Joseph Sarah, Pierce Benjamin F, Shattock Robin J, Kaleebu Pontiano
